Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation
Clinical trial NCT00224406 · COMPLETED
Trial details
- NCT number
- NCT00224406
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2006-09-13
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.